Pandemic preparedness is a continual process to ensure that when the need arises, drug developers, industry partners and government agencies can come together to proactively address emerging public health threats.
Close and careful coordination across stakeholders is vital to successfully addressing emergent and present threats to public health, especially when response is needed on a global scale. Key to preparation is the advanced identification of resource gaps and strategic response blind spots. This introspective analysis is critical to creating a strong foundation for robust pandemic response strategy by enabling the early identification of partners who can effectively support response efforts.
Coordinating with multiple partners, especially in times of crisis and uncertainty, is not without its challenges. This webinar will explore how a full-service clinical research organization (CRO) having contract development and manufacturing organization (CDMO) capabilities (CDMO) approaches pandemic preparedness to ensure a comprehensive and coordinated response with the necessary agility and speed to address public health emergencies.
The expert speakers will discuss how they can collaborate to expedite therapeutic and vaccine development when time is of the absolute essence and share real-world examples and lessons learned.
Register for this webinar today to learn how to enhance pandemic preparedness by establishing relevant partnerships that can help expedite therapeutic and vaccine development.
Speakers
Vanessa Elharrar, MD, MPH, Global Medical Officer, Vaccines and Government and Public Health Services, PPD Clinical Research Business of Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Olivia Aspite, Executive Director, Lab Operations, PPD Clinical Research Business of Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Jennifer Crager, Executive Director, Digital Implementation, Patient First Digital Solutions, PPD Clinical Research Business of Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Allison Grande, Senior Business Development Manager, Public Health, Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Kelly Howard, VP, Commercial Operations, VVS Global & Advanced Therapies, Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Lisa Kierstead, Executive Director, Vaccines Lab, PPD Clinical Research Business of Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Pam Launt, Executive Director, Biostatistics & Programming, PPD Clinical Research Business of Thermo Fisher Scientific
Bio Coming soon.
Message Presenter
Krista Payne, VP & General Manager, Evidera, part of the PPD clinical research business of Thermo Fisher Scientific
Bio Coming soon.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Employees of biopharma and biotech companies involved in site selection, study management and forecasting and patient recruitment for clinical research and/or clinical trial initiatives
- Investigators/Site Directors of clinical research sites
- Individuals involved in pandemic preparedness, emergency response to public health threats, infectious disease and vaccine research and development initiatives
What You Will Learn
Attendees will learn about:
- The importance of pandemic preparedness and how it can be achieved
- What it takes to manufacture pharmaceutical products and launch clinical trials during a public health emergency
- The pivotal role of laboratory services and how scale can be achieved in the face of emergent health threats
- How real-world evidence (RWE) and mathematical modeling capabilities have taken on new importance in expedited clinical development programs
- How decentralized solutions ensure clinical research continues in times of uncertainty
Xtalks Partner
Thermo Fisher Scientific Inc
The PPD clinical research business is part of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, we serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, we apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account